The Food and Drug Administration granted breakthrough therapy designation to Arrowhead Pharmaceuticals' plozasiran drug to treat severe hypertriglyceridemia. The designation expedites the development ...
We’re back in New York court this morning for pre-trial hearings on whether key evidence in the UnitedHealthcare CEO shooting ...
YouTube released its annual end-of-the-year trending lists for 2025 and launched the first YouTube Recap, a personalized, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback